Rohr Christine I, Clements John M, Sarkar Arup
Department of Medical Education, Synergy Medical Education Alliance, 1000 Houghton Ave, Saginaw, MI 48602-5303, USA.
J Am Osteopath Assoc. 2006 Jul;106(7):396-401.
To determine the use of treatment and prevention practices in postmenopausal women who have received the results of an osteoporosis screening.
Telephone survey to follow-up with women who underwent dual-energy x-ray absorptiometry scanning at a community-wide osteoporosis screening project. Participants categorized by their scan results as having normal bone mineral density or low bone mineral density were asked about their osteoporosis treatment and prevention practices since receiving their scan results.
Two hundred nineteen women were interviewed. Calcium supplement use increased significantly in both groups (P=.002). There was no significant difference in the number of women using alendronate sodium, calcitonin, and selective estrogen receptor modulators before and after screening. Both groups reported increases in exercise levels and dairy intake, but the difference was not statistically significant.
Our results indicate that the use of over-the-counter calcium supplements increases after osteoporosis screening. However, the use of treatments that require a physician prescription does not increase after screening regardless of the patient's bone mineral density status.
确定已收到骨质疏松症筛查结果的绝经后女性对治疗和预防措施的使用情况。
通过电话调查对在社区范围的骨质疏松症筛查项目中接受双能X线吸收测定扫描的女性进行随访。将根据扫描结果分类为骨矿物质密度正常或骨矿物质密度低的参与者询问自收到扫描结果以来她们的骨质疏松症治疗和预防措施。
对219名女性进行了访谈。两组中钙补充剂的使用均显著增加（P = 0.002）。筛查前后使用阿仑膦酸钠、降钙素和选择性雌激素受体调节剂的女性人数无显著差异。两组均报告运动水平和乳制品摄入量增加，但差异无统计学意义。
我们的结果表明，骨质疏松症筛查后非处方钙补充剂的使用增加。然而，无论患者的骨矿物质密度状况如何，筛查后需要医生处方的治疗方法的使用并未增加。
